Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting

OBJECTIVES: In an acute heart failure (AHF) setting, proenkephalin A 119–159 (penKid) has emerged as a promising prognostic marker for predicting worsening renal function (WRF), while bioactive adrenomedullin (bio-ADM) has been proposed as a potential marker for congestion. We examined the diagnosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Molvin, John, Jujic, Amra, Navarin, Silvia, Melander, Olle, Zoccoli, Giada, Hartmann, Oliver, Bergmann, Andreas, Struck, Joachim, Bachus, Erasmus, Di Somma, Salvatore, Magnusson, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Heart Failure and Cardiomyopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615850/
https://www.ncbi.nlm.nih.gov/pubmed/31354956
http://dx.doi.org/10.1136/openhrt-2019-001048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615850/
https://www.ncbi.nlm.nih.gov/pubmed/31354956
http://dx.doi.org/10.1136/openhrt-2019-001048

Ejemplares similares